Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 12/20 | 0.39 |
| ▸ | TAS2R46 | P59540 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9325972 | 0.89 | ALOX15 (0.51) | ALOX15TSHRUSP2CYP3A4HSD11B1 | |
| SCHEMBL9326508 | 0.89 | ALOX15 (0.51) | ALOX15TSHRUSP2CYP3A4HSD11B1 | |
| SCHEMBL9325975 | 0.89 | ALOX15 (0.51) | ALOX15TSHRUSP2CYP3A4HSD11B1 | |
| SCHEMBL15083626 | 0.83 | ALOX15 (0.41) | ALOX15TSHRUSP2CYP3A4HSD11B1 | |
| SCHEMBL7457038 | 0.80 | CYP19A1 (0.38) | ALOX15TSHRUSP2CYP3A4HSD11B1 | |
| SCHEMBL17213227 | 0.80 | ALOX15 (0.35) | ALOX15TSHRUSP2CYP3A4 | |
| SCHEMBL3003039 | 0.77 | CYP19A1 (0.39) | ALOX15TSHRCYP19A1TAS2R46CHRM2 | |
| SCHEMBL20623071 | 0.77 | MEN1 (0.46) | TSHRCHRM2CHRM4CHRM1CHRM3 | |
| SCHEMBL11126526 | 0.76 | — | — | |
| SCHEMBL8746914 | 0.76 | TLR4 (0.42) | ALOX15TSHRCYP19A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10336781-B2 | Recyclable metathesis catalysts | THE TRUSTEES OF BOSTON COLLEGE (US) | 2019-07-02 | — | — | US | disclosed |
| EP-2752401-B1 | PRODUCTION METHOD FOR 2-ALKENYLAMINE COMPOUND | SHOWA DENKO KK (JP) | 2018-10-10 | — | — | EP | disclosed |
| EP-2752402-B1 | PRODUCTION METHOD FOR 2-ALKENYLAMINE COMPOUND | SHOWA DENKO KK (JP) | 2018-06-27 | — | — | EP | disclosed |
| US-9440907-B2 | Production method for 2-alkenylamine compound | SHOWA DENKO K.K. (JP) | 2016-09-13 | — | — | US | disclosed |
| US-20160168181-A1 | RECYCLABLE METATHESIS CATALYSTS | THE TRUSTEES OF BOSTON COLLEGE | 2016-06-16 | — | — | US | disclosed |
| US-20160168181-A1 | RECYCLABLE METATHESIS CATALYSTS | THE TRUSTEES OF BOSTON COLLEGE | 2016-06-16 | — | — | US | disclosed |
| US-9346740-B2 | Production method for 2-alkenylamine compound | SHOWA DENKO K.K. (JP) | 2016-05-24 | — | — | US | disclosed |
| CN-103748065-B | Method for producing 2-alkenylamine compound | SHOWA DENKO KABUSHIKI KAISHA (JP) | 2015-12-23 | — | — | CN | disclosed |
| EP-2752402-A1 | PRODUCTION METHOD FOR 2-ALKENYLAMINE COMPOUND | Showa Denko K.K. (JP) | 2014-07-09 | — | — | EP | disclosed |
| EP-2752401-A1 | PRODUCTION METHOD FOR 2-ALKENYLAMINE COMPOUND | Showa Denko K.K. (JP) | 2014-07-09 | — | — | EP | disclosed |
| US-7173157-B2 | Method for producing an allyl compound | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-02-06 | — | — | US | disclosed |
| US-7119222-B2 | Method for producing allyl compound, and ether or ester compound produced thereby | MITSUBISHI CHEMICAL CORPORATION (JP) | 2006-10-10 | — | — | US | disclosed |
| US-20060106181-A1 | Method for producing allyl compound, and ether or ester compound produced thereby | MITSUBISHI CHEMICAL CORPORATION (JP) | 2006-05-18 | — | — | US | disclosed |
| US-20050075518-A1 | Method for producing allyl compound, and allyl compound produced thereby | MITSUBISHI CHEMICAL CORPORATION (JP) | 2005-04-07 | — | — | US | disclosed |
| US-20040147757-A1 | Method for producing allyl compound, and ether or ester compound produced thereby | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-07-29 | — | — | US | disclosed |
| US-20040092777-A1 | Method for producing allyl compound | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-05-13 | — | — | US | disclosed |
| CN-1071736-C | A process for the preparation of carboxylic esters derived from allylic alcohols | FIRMENICH & CIE (CH) | 2001-09-26 | — | — | CN | disclosed |
| US-5554786-A | Process for the preparation of carboxylic esters defined from allylic alcohols | FIRMENICH S.A. (CH) | 1996-09-10 | — | — | US | disclosed |
| CN-1113226-A | A process for the preparation of carboxylic esters derived from allylic alcohols | FIRMENICH & CIE (CH) | 1995-12-13 | — | — | CN | disclosed |
| US-4069385-A | FROM AN OLEFIN AND AN ORGANIC PEROXIDE WITH COPPER-SCHIFF BASE COMPEX AS CATALYST | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1978-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060106181-A1 | Method for producing allyl compound, and ether or ester compound produced thereby | AGPAT5, TST, AGPAT2 | ALOX15 46/4885TSHR 4449/4885USP2 4450/4885 |
| US-20040147757-A1 | Method for producing allyl compound, and ether or ester compound produced thereby | AGPAT5, TST, AGPAT2 | ALOX15 46/4885TSHR 4449/4885USP2 4450/4885 |
| US-10336781-B2 | Recyclable metathesis catalysts | DNMT1, CARM1, ZMYND8 | ALOX15 2782/4885TSHR 1343/4885USP2 1295/4885 |
| US-20160168181-A1 | RECYCLABLE METATHESIS CATALYSTS | DNMT1, CARM1, ZMYND8 | ALOX15 2782/4885TSHR 1343/4885USP2 1295/4885 |
| US-20040092777-A1 | Method for producing allyl compound | CCNT1, APEX1, REV1 | ALOX15 547/4885TSHR 4147/4885USP2 4248/4885 |
| US-20050075518-A1 | Method for producing allyl compound, and allyl compound produced thereby | CCNT1, AOC3, ATL3 | ALOX15 301/4885TSHR 3258/4885USP2 4794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.